`
`__________
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`__________
`
`
`REGENERON PHARMACEUTICALS, INC.,
`Petitioner
`
`v.
`
`NOVARTIS PHARMA AG,
`NOVARTIS TECHNOLOGY LLC,
`NOVARTIS PHARMACEUTICALS CORPORATION,
`Patent Owners
`
`__________
`
`
`Case IPR2021-00816
`Patent 9,220,631
`
`__________
`
`
`JOINT STIPULATION TO MODIFY DUE DATES 1 AND 2
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 9,220,631
`Patent Owners Novartis Pharma AG, Novartis Technology LLC, and
`
`
`
`Novartis Pharmaceuticals Corporation, and Petitioner Regeneron Pharmaceuticals,
`
`Inc. hereby stipulate to the following modifications to DUE DATE 1 and DUE
`
`DATE 2:
`
`
`
`DUE DATE 1
`
`DUE DATE 2
`
`Current Date
`
`Stipulated Date
`
`January 18, 2022
`
`January 19, 2022
`
`April 12, 2022
`
`April 13, 2022
`
`
`
`
`
`This stipulation does not affect or otherwise modify the dates for any other
`
`DUE DATES in the Scheduling Order.
`
`
`Dated: January 19, 2022
`
`
`
`
`
`/Elizabeth Holland/
`By:
`Elizabeth J. Holland (Reg. No. 47,657)
`Lead Counsel for Patent Owners
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Phone: (212) 813-8800
`Fax: (212) 355-3333
`EHolland@goodwinlaw.com
`
`
`
`
`/Christopher Pepe/
`By:
`Christopher M. Pepe (Reg No. 73,851)
`Back-Up Counsel for Petitioner
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`
`
`
`
`
`
`
`
`
`
`
`U.S. Patent No. 9,220,631
`CERTIFICATE OF SERVICE
`A copy of this JOINT STIPULATION TO MODIFY DUE DATES 1 AND
`
`2 has been served on Petitioner’s attorneys of record as follows via electronic mail
`
`on this 19th day of January 2022:
`
`Elizabeth Stotland Weiswasser (Reg. No. 55,721)
`Anish R. Desai (Reg No. 73,760)
`Natalie Kennedy (Reg No. 68,511)
`Andrew Gesior (Reg No. 76,588)
`Weil, Gotshal & Manges LLP
`767 Fifth Avenue
`New York, NY 10153
`T: 212-310-8022
`F: 212-310-8007
`Regeneron.IPR.Service@weil.com
`
`Brian E. Ferguson (Reg No. 36,801)
`Christopher M. Pepe (Reg No. 73,851)
`Weil, Gotshal & Manges LLP
`2001 M Street, N.W., Suite 600
`Washington, D.C. 20036
`T: 202-682-7000
`F: 202-857-0940
`Regeneron.IPR.Service@weil.com
`Attorneys for Regeneron Pharmaceuticals, Inc.
`
`Dated: January 19, 2022
`
`By:
`
`
`
`
`/Elizabeth Holland/
`Elizabeth J. Holland (Reg. No. 47,657)
`Lead Counsel for Patent Owners
`Goodwin Procter LLP
`620 Eighth Avenue
`New York, NY 10018
`Phone: (212) 813-8800
`Fax: (212) 355-3333
`EHolland@goodwinlaw.com
`
`